RPG Life Sciences (NSE:RPGLIFE) EV-to-FCF: (As of Jul. 11, 2026)


NSE:RPGLIFE RPG Life Sciences Ltd NSE:RPGLIFE
88 GF Score
Price ₹2,856.90
GF Value ₹2,356.49
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is RPG Life Sciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, RPG Life Sciences's Enterprise Value is ₹44,707 Mil. RPG Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0 Mil. Therefore, RPG Life Sciences's EV-to-FCF for today is .

The historical rank and industry rank for RPG Life Sciences's EV-to-FCF or its related term are showing as below:

NSE:RPGLIFE' s EV-to-FCF Range Over the Past 10 Years
Min: -429.06   Med: 0   Max: 0
Current: -429.06

NSE:RPGLIFE's EV-to-FCF is ranked worse than
100% of 562 companies
in the Drug Manufacturers industry
Industry Median: 20.765 vs NSE:RPGLIFE: -429.06

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-11), RPG Life Sciences's stock price is ₹2856.90. RPG Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹69.640. Therefore, RPG Life Sciences's PE Ratio (TTM) for today is 41.02.


RPG Life Sciences  (NSE:RPGLIFE) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

RPG Life Sciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2856.90/69.640
=41.02

RPG Life Sciences's share price for today is ₹2856.90.
RPG Life Sciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹69.640.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


RPG Life Sciences EV-to-FCF Related Terms


RPG Life Sciences EV-to-FCF Historical Data

* Premium members only.

The historical data trend for RPG Life Sciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RPG Life Sciences EV-to-FCF Chart

RPG Life Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.03 17.97 95.58 83.88 -318.07

RPG Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.88 0.00 0.00 0.00 -318.07

NSE:RPGLIFE vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RPG Life Sciences EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's EV-to-FCF falls into.


NSE:RPGLIFE
88GF Score
RPG Life Sciences Ltd NSE:RPGLIFE
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RPG Life Sciences EV-to-FCF Calculation

RPG Life Sciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=44706.612/0
=

RPG Life Sciences's current Enterprise Value is ₹44,707 Mil.
RPG Life Sciences's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is RPG Life Sciences (NSE:RPGLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, RPG Life Sciences stock appears to be overvalued. The current stock price of ₹2,856.90 is trading 21.2% above its estimated GF Value™ of ₹2,356.49. GuruFocus considers RPG Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:RPGLIFE:

  • EV-to-FCF:
  • GF Value™: ₹2,356.49 vs. price of ₹2,856.90 (21.2% above fair value)
  • GF Score™: 88/100 with 6 warning signs

No single metric tells the full story. See the NSE:RPGLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


RPG Life Sciences Business Description

Other Exchanges 532983:India
Address 463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.
88GF Score

Get the complete analysis for NSE:RPGLIFE

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹2,856.90
Price
₹2,356.49
GF Value